cfDNA is an acceptable but insufficient means of characterizing FGFR3 mutation in patients with metastatic urothelial cancer (mUC) Meeting Abstract
| Authors: | Pal, S. K.; Bajorin, D. F.; Hoffman-Censits, J. H.; Quinn, D. I.; Petrylak, D. P.; Galsky, M. D.; Vaishampayan, U. N.; De Giorgi, U.; Gupta, S.; Burris, H. A.; Soifer, H. S.; Li, G.; Dambkowski, C. L.; Moran, S.; Wang, H.; Daneshmand, S.; Rosenberg, J. E. |
| Abstract Title: | cfDNA is an acceptable but insufficient means of characterizing FGFR3 mutation in patients with metastatic urothelial cancer (mUC) |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | v377 |
| End Page: | v378 |
| Language: | English |
| ACCESSION: | WOS:000491295502365 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz249.037 |
| Notes: | Meeting Abstract: 940P -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
